Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101927787 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100132078 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THADA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CMC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKCQ-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IGHV3-23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HELZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505549 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WFDC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP250 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORCS3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMPCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLCN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on